/Investor DB

Refactor Capital — 2022 Investments

9 investments dated 2022 · listed companies and verified rows first · show all

Solugensolugen.comin𝕏Seed · Dec 2022 · $200M✓ verified

Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.

Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US

Sean Hunt(CTO, Co-Founder)inGaurab Chakrabarti(CEO, Co-Founder)inJonathan Tang(Investor)inSlava Solonitsyn(Investor)in

BoardSeth Bannon(Director)in

Co-investorsFifty YearsFounders FundKdT VenturesLowercarbon CapitalY CombinatorBaillie Gifford+41 more

64x64-x.comin𝕏Jan 2022

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.

BiotechDeep TechMedical Devices

Co-investorsBoxGroupFirst Round CapitalFifty YearsFuture VenturesLifeforce CapitalNorthpond Ventures+1 more

64x Bio64xbio.comin𝕏Seed · Jan 2022 · $55M

64x Bio develops cell-line engineering and production technologies to overcome manufacturing bottlenecks in advanced and next-generation therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)

Co-investorsFifty YearsFuture VenturesG VenturesLifeforce CapitalRaptor GroupY Combinator+8 more

Evernowevernow.cominSep 2022 · $28.5M

Evernow provides personalized, longitudinal menopause care for women, offering access to menopause providers, treatments, and ongoing support.

Digital HealthFemTechWellness & Fitness

Alicia Jackson(Founder)in

Co-investorsAlumni VenturesEnsemble LabsGaingelsNew Enterprise Associates (NEA)8VCCoelius Capital

Fleetzerofleetzero.comin𝕏Seed · Jun 2022

Fleetzero designs and retrofits commercial vessels with battery-electric propulsion systems to decarbonize ocean shipping.

Advanced ManufacturingCleantechClimate TechEnergyHardwareRoboticsHouston, US

Steven Henderson(Founder)inMike Carter(Founder)inSteven H(Founder)Steven Henderson Michael Carter(Founder)Thomas Smillie(Vice President Engineering)Maggie Belshe(Marketing)

Co-investorsObvious VenturesBreakthrough Energy VenturesCantos VenturesDarco CapitalMaersk GrowthPioneer+10 more

Fytofyto.com𝕏Jul 2022

From Yellow To Orange (fyto) is a Japanese company that produces and distributes music and video, composes and arranges music, and plans, develops, and sells games and digital content.

ConsumerGamingMedia & EntertainmentPetaluma, US

Kenji Eno(Founder)Yuka Iino(Representative Director (CEO))Jason Prapas(Executive Officer, Director)Harold Kruth(Director)Andy Wheeler(Director)

Co-investorsAgFunderGV (Google Ventures)City LightFirst Star Ventures

Fytofyto.usJul 2022

Fyto develops nutrient recycling and protein production technology for farmers, enabling sustainable food production with reduced environmental impact.

AgTechClimate TechFoodTechRoboticsSan Francisco Bay Area, US

Jason Prapas(Founder)

Co-investorsCity LightAgFunderBaukunstFirst Star VenturesGV (Google Ventures)

Parallel Bioparallel.bioin𝕏Seed · Dec 2022 · $4M

Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

Robert DiFazio(Co-Founder & Co-CEO)inJuliana Hilliard(Co-Founder & Co-CEO)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)

Co-investorsAIX VenturesBreakout VenturesGaingelsHumba VenturesImmeasurableJulian Capital+19 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Vitra Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.